Venlafaxine controlled release - Sun Pharma Advanced Research Company

Drug Profile

Venlafaxine controlled release - Sun Pharma Advanced Research Company

Alternative Names: Venlafaxine ER - Sun Pharma Advanced Research Company; Venlafaxine extended release - Sun Pharma Advanced Research Company

Latest Information Update: 08 Jun 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Antidepressants; Anxiolytics; Cyclohexanols; Dimethylamines; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Depressive disorders

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 01 Mar 2014 Preregistration for Depressive disorders in USA (PO,controlled release)
  • 17 Dec 2013 Sun Pharma Advanced Research Company received complete response letter for venlafaxine controlled release from the US FDA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top